{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:19:27Z","timestamp":1794262767586,"version":"4.9.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201210"],"award-info":[{"award-number":["82201210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222030"],"award-info":[{"award-number":["82222030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2023NSFSC1660"],"award-info":[{"award-number":["2023NSFSC1660"]}]},{"name":"Postdoctor Research Fund of West China Hospital, Sichuan University","award":["2024HXBH082"],"award-info":[{"award-number":["2024HXBH082"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3403300"],"award-info":[{"award-number":["2023YFC3403300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University","award":["ZYYC23009"],"award-info":[{"award-number":["ZYYC23009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12015-025-10949-x","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:43:02Z","timestamp":1755654182000},"page":"2386-2406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advances in Stem Cell Therapies for Ocular Diseases: Progress in Clinical Trials and Future Perspectives"],"prefix":"10.1007","volume":"21","author":[{"given":"Fanfei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"4","key":"10949_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663\u2013676.","journal-title":"Cell"},{"issue":"52","key":"10949_CR2","first-page":"E11111","volume":"114","author":"MT Zhao","year":"2017","unstructured":"Zhao, M. T., Chen, H., Liu, Q., Shao, N. Y., Sayed, N., Wo, H. T., Zhang, J. Z., Ong, S. G., Liu, C., & Kim, Y. (2017). Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs. Proceedings of the National Academy of Sciences of the United States of America,114(52), E11111\u2013E11120.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10949_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12015-018-9811-3","volume":"14","author":"R Ben Jehuda","year":"2018","unstructured":"Ben Jehuda, R., Shemer, Y., & Binah, O. (2018). Genome editing in induced pluripotent stem cells using CRISPR\/Cas9. Stem Cell Reviews and Reports, 14, 323\u2013336.","journal-title":"Stem Cell Reviews and Reports"},{"key":"10949_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jchemneu.2018.02.002","volume":"95","author":"R Rathod","year":"2019","unstructured":"Rathod, R., Surendran, H., Battu, R., Desai, J., & Pal, R. (2019). Induced pluripotent stem cells (iPSC)-derived retinal cells in disease modeling and regenerative medicine. Journal of Chemical Neuroanatomy, 95, 81\u201388.","journal-title":"Journal of Chemical Neuroanatomy"},{"issue":"9","key":"10949_CR5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.ymthe.2017.05.015","volume":"25","author":"ER Burnight","year":"2017","unstructured":"Burnight, E. R., Gupta, M., Wiley, L. A., Anfinson, K. R., Tran, A., Triboulet, R., Hoffmann, J. M., Klaahsen, D. L., Andorf, J. L., & Jiao, C. (2017). Using CRISPR-Cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration. Molecular Therapy, 25(9), 1999\u20132013.","journal-title":"Molecular Therapy"},{"issue":"1","key":"10949_CR6","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang, W., & Xu, J. (2020). Immune modulation by mesenchymal stem cells. Cell Proliferation, 53(1), e12712.","journal-title":"Cell Proliferation"},{"issue":"7","key":"10949_CR7","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3390\/ijms21072318","volume":"21","author":"EN Worthington","year":"2020","unstructured":"Worthington, E. N., & Hagood, J. S. (2020). Therapeutic use of extracellular vesicles for acute and chronic lung disease. International Journal of Molecular Sciences, 21(7), 2318.","journal-title":"International Journal of Molecular Sciences"},{"key":"10949_CR8","doi-asserted-by":"crossref","unstructured":"Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022). Induced pluripotent stem cells: Progress toward clinical translation from bench to bedside. Handbook of Stem Cell Therapy, 1\u201325.","DOI":"10.1007\/978-981-16-6016-0_40-1"},{"key":"10949_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.11.001","volume":"69","author":"SJ Gasparini","year":"2019","unstructured":"Gasparini, S. J., Llonch, S., Borsch, O., & Ader, M. (2019). Transplantation of photoreceptors into the degenerative retina: Current state and future perspectives. Progress in Retinal and Eye Research, 69, 1\u201337.","journal-title":"Progress in Retinal and Eye Research"},{"issue":"8","key":"10949_CR10","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3267","volume":"19","author":"AS Lee","year":"2013","unstructured":"Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., & Wu, J. C. (2013). Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nature Medicine, 19(8), 998\u20131004.","journal-title":"Nature Medicine"},{"issue":"5","key":"10949_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.stem.2019.10.001","volume":"25","author":"M Desgres","year":"2019","unstructured":"Desgres, M., & Menasche, P. (2019). Clinical translation of pluripotent stem cell therapies: Challenges and considerations. Cell Stem Cell,25(5), 594\u2013606.","journal-title":"Cell Stem Cell"},{"key":"10949_CR12","doi-asserted-by":"publisher","DOI":"10.1242\/dev.202067","author":"JR Christiansen","year":"2024","unstructured":"Christiansen, J. R., & Kirkeby, A. (2024). Clinical translation of pluripotent stem cell-based therapies: Successes and challenges. Development (Cambridge, England). https:\/\/doi.org\/10.1242\/dev.202067","journal-title":"Development (Cambridge, England)"},{"issue":"1657","key":"10949_CR13","doi-asserted-by":"publisher","first-page":"20130541","DOI":"10.1098\/rstb.2013.0541","volume":"369","author":"T Boroviak","year":"2014","unstructured":"Boroviak, T., & Nichols, J. (2014). The birth of embryonic pluripotency. Philosophical Transactions of the Royal Society B: Biological Sciences, 369(1657), 20130541.","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"issue":"5","key":"10949_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.copbio.2007.09.007","volume":"18","author":"M Lewitzky","year":"2007","unstructured":"Lewitzky, M., & Yamanaka, S. (2007). Reprogramming somatic cells towards pluripotency by defined factors. Current Opinion in Biotechnology, 18(5), 467\u2013473.","journal-title":"Current Opinion in Biotechnology"},{"key":"10949_CR15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00109-008-0383-6","volume":"86","author":"S Hombach-Klonisch","year":"2008","unstructured":"Hombach-Klonisch, S., Panigrahi, S., Rashedi, I., Seifert, A., Alberti, E., Pocar, P., Kurpisz, M., Schulze-Osthoff, K., Mackiewicz, A., & Los, M. (2008). Adult stem cells and their trans-differentiation potential\u2014perspectives and therapeutic applications. Journal of Molecular Medicine, 86, 1301\u20131314.","journal-title":"Journal of Molecular Medicine"},{"issue":"1","key":"10949_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T., Nguyen, Q. T., Phan, T. T., Nguyen, G. H., Le, P. T., Hoang, V. T., & Forsyth, N. R. (2022). Stem cell-based therapy for human diseases. Signal Transduction and Targeted Therapy,7(1), Article 272.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10949_CR17","doi-asserted-by":"crossref","unstructured":"Jin, C., Wu, P., Li, L., Xu, W., & Qian, H. (2021). Exosomes: emerging therapy delivery tools and biomarkers for kidney diseases. Stem Cells International, 2021.","DOI":"10.1155\/2021\/7844455"},{"issue":"4","key":"10949_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney, D. G., & Pittenger, M. F. (2017). Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells, 35(4), 851\u2013858.","journal-title":"Stem Cells"},{"issue":"7","key":"10949_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou, M., Huang, L., Yang, J., Chiang, Z., Chen, S., Liu, J., Guo, L., Zhang, X., Zhou, X., & Xu, X. (2022). Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: A next generation therapeutic tool? Cell Death & Disease,13(7), 580.","journal-title":"Cell Death & Disease"},{"issue":"4","key":"10949_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/stcltm\/szad012","volume":"12","author":"WJ Cho","year":"2023","unstructured":"Cho, W. J., Mittal, S. K., & Chauhan, S. K. (2023). Mesenchymal stromal cells suppress T-cell-mediated delayed-type hypersensitivity via ALCAM-CD6 interaction. Stem Cells Translational Medicine, 12(4), 221\u2013233.","journal-title":"Stem Cells Translational Medicine"},{"issue":"1","key":"10949_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/sctm.20-0118","volume":"10","author":"LJ Beeken","year":"2021","unstructured":"Beeken, L. J., Ting, D. S., & Sidney, L. E. (2021). Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders. Stem Cells Translational Medicine,10(1), 39\u201349.","journal-title":"Stem Cells Translational Medicine"},{"issue":"6","key":"10949_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/MOT.0000000000000360","volume":"21","author":"N Murphy","year":"2016","unstructured":"Murphy, N., Lynch, K., Lohan, P., Treacy, O., & Ritter, T. (2016). Mesenchymal stem cell therapy to promote corneal allograft survival: Current status and pathway to clinical translation. Current Opinion in Organ Transplantation, 21(6), 559\u2013567.","journal-title":"Current Opinion in Organ Transplantation"},{"issue":"2","key":"10949_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10214","volume":"6","author":"LLW Wang","year":"2021","unstructured":"Wang, L. L. W., Janes, M. E., Kumbhojkar, N., Kapate, N., Clegg, J. R., Prakash, S., Heavey, M. K., Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2021). Cell therapies in the clinic. Bioengineering & Translational Medicine,6(2), Article e10214.","journal-title":"Bioengineering & Translational Medicine"},{"key":"10949_CR24","doi-asserted-by":"publisher","first-page":"959658","DOI":"10.3389\/fimmu.2022.959658","volume":"13","author":"E Stenger","year":"2022","unstructured":"Stenger, E., Giver, C. R., Langston, A., Kota, D., Das, P. K., Chinnadurai, R., Galipeau, J., Waller, E. K., & Qayed, M. (2022). Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease. Frontiers in Immunology, 13, 959658.","journal-title":"Frontiers in Immunology"},{"key":"10949_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00109-019-01776-y","volume":"97","author":"LL de Castro","year":"2019","unstructured":"de Castro, L. L., Lopes-Pacheco, M., Weiss, D. J., Cruz, F. F., & Rocco, P. R. M. (2019). Current understanding of the immunosuppressive properties of mesenchymal stromal cells. Journal of Molecular Medicine,97, 605\u2013618.","journal-title":"Journal of Molecular Medicine"},{"key":"10949_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jtos.2023.03.002","volume":"28","author":"L Wang","year":"2023","unstructured":"Wang, L., Wang, X., Chen, Q., Wei, Z., Xu, X., Han, D., Zhang, Y., Chen, Z., & Liang, Q. (2023). Micrornas of extracellular vesicles derived from mesenchymal stromal cells alleviate inflammation in dry eye disease by targeting the IRAK1\/Table 2\/NF-\u03baB pathway. The Ocular Surface,28, 131\u2013140.","journal-title":"The Ocular Surface"},{"key":"10949_CR27","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s12015-019-09908-0","volume":"15","author":"B Hermankova","year":"2019","unstructured":"Hermankova, B., Kossl, J., Bohacova, P., Javorkova, E., Hajkova, M., Krulova, M., Zajicova, A., & Holan, V. (2019). The immunomodulatory potential of mesenchymal stem cells in a retinal inflammatory environment. Stem Cell Reviews and Reports,15, 880\u2013891.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"2","key":"10949_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13577-016-0134-x","volume":"29","author":"K Song","year":"2016","unstructured":"Song, K., Li, L., Wang, Y., & Liu, T. (2016). Hematopoietic stem cells: Multiparameter regulation. Human Cell, 29(2), 53\u201357. https:\/\/doi.org\/10.1007\/s13577-016-0134-x","journal-title":"Human Cell"},{"key":"10949_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12015-011-9228-8","volume":"7","author":"C Pontikoglou","year":"2011","unstructured":"Pontikoglou, C., Deschaseaux, F., Senseb\u00e9, L., & Papadaki, H. A. (2011). Bone marrow mesenchymal stem cells: Biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Reviews and Reports, 7, 569\u2013589.","journal-title":"Stem Cell Reviews and Reports"},{"key":"10949_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clineuro.2018.07.013","volume":"173","author":"C Grochowski","year":"2018","unstructured":"Grochowski, C., Radzikowska, E., & Maciejewski, R. (2018). Neural stem cell therapy\u2014Brief review. Clinical Neurology and Neurosurgery, 173, 8\u201314.","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"5","key":"10949_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1167\/iovs.66.5.45","volume":"66","author":"Y Li","year":"2025","unstructured":"Li, Y., & Liu, Y. (2025). Recent advances in stem cells of corneal epithelia. Investigative Ophthalmology & Visual Science,66(5), 45\u201345.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10949_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","volume":"16","author":"H Gehart","year":"2019","unstructured":"Gehart, H., & Clevers, H. (2019). Tales from the crypt: New insights into intestinal stem cells. Nature Reviews Gastroenterology & Hepatology,16(1), 19\u201334.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10949_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13770-020-00312-1","volume":"18","author":"C Lam","year":"2021","unstructured":"Lam, C., Alsaeedi, H. A., Koh, A. E. H., Harun, M. H. N., Hwei, A. N. M., Mok, P. L., Luu, C. D., Yong, T. K., Subbiah, S. K., & Bastion, M. L. C. (2021). Human dental pulp stem cells (DPSCs) therapy in rescuing photoreceptors and establishing a sodium iodate-induced retinal degeneration rat model. Tissue Engineering and Regenerative Medicine,18, 143\u2013154.","journal-title":"Tissue Engineering and Regenerative Medicine"},{"issue":"12","key":"10949_CR34","doi-asserted-by":"publisher","first-page":"7544","DOI":"10.1167\/iovs.13-13045","volume":"54","author":"B Mead","year":"2013","unstructured":"Mead, B., Logan, A., Berry, M., Leadbeater, W., & Scheven, B. A. (2013). Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury. Investigative Ophthalmology & Visual Science,54(12), 7544\u20137556.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10949_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuroscience.2014.09.023","volume":"280","author":"A Bray","year":"2014","unstructured":"Bray, A., Cevallos, R., Gazarian, K., & Lamas, M. (2014). Human dental pulp stem cells respond to cues from the rat retina and differentiate to express the retinal neuronal marker rhodopsin. Neuroscience, 280, 142\u2013155.","journal-title":"Neuroscience"},{"issue":"6","key":"10949_CR36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41423-023-00998-y","volume":"20","author":"P Li","year":"2023","unstructured":"Li, P., Ou, Q., Shi, S., & Shao, C. (2023). Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications. Cellular and Molecular Immunology,20(6), 558\u2013569.","journal-title":"Cellular and Molecular Immunology"},{"key":"10949_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-015-0005-4","volume":"13","author":"N Desai","year":"2015","unstructured":"Desai, N., Rambhia, P., & Gishto, A. (2015). Human embryonic stem cell cultivation: Historical perspective and evolution of xeno-free culture systems. Reproductive Biology and Endocrinology, 13, 1\u201315.","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"1","key":"10949_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4252\/wjsc.v13.i1.1","volume":"13","author":"D Kumar","year":"2021","unstructured":"Kumar, D., Talluri, T. R., Selokar, N. L., Hyder, I., & Kues, W. A. (2021). Perspectives of pluripotent stem cells in livestock. World Journal of Stem Cells, 13(1), 1.","journal-title":"World Journal of Stem Cells"},{"key":"10949_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","volume":"16","author":"G Liu","year":"2020","unstructured":"Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2020). Advances in pluripotent stem cells: History, mechanisms, technologies, and applications. Stem Cell Reviews and Reports, 16, 3\u201332.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"8","key":"10949_CR40","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/sctm.19-0396","volume":"9","author":"S Petrus-Reurer","year":"2020","unstructured":"Petrus-Reurer, S., Kumar, P., Padrell S\u00e1nchez, S., Aronsson, M., Andr\u00e9, H., Bartuma, H., Plaza Reyes, A., Nandrot, E. F., Kvanta, A., & Lanner, F. (2020). Preclinical safety studies of human embryonic stem cell-derived retinal pigment epithelial cells for the treatment of age-related macular degeneration. Stem Cells Translational Medicine, 9(8), 936\u2013953.","journal-title":"Stem Cells Translational Medicine"},{"issue":"2","key":"10949_CR41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.stemcr.2020.06.019","volume":"15","author":"E Aboualizadeh","year":"2020","unstructured":"Aboualizadeh, E., Phillips, M. J., McGregor, J. E., DiLoreto, D. A., Jr., Strazzeri, J. M., Dhakal, K. R., Bateman, B., Jager, L. D., Nilles, K. L., Stuedemann, S. A., Ludwig, A. L., Hunter, J. J., Merigan, W. H., Gamm, D. M., & Williams, D. R. (2020). Imaging transplanted photoreceptors in living nonhuman primates with single-cell resolution. Stem Cell Reports,15(2), 482\u2013497. https:\/\/doi.org\/10.1016\/j.stemcr.2020.06.019","journal-title":"Stem Cell Reports"},{"issue":"9967","key":"10949_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","volume":"385","author":"SD Schwartz","year":"2015","unstructured":"Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J. P., Davis, J. L., Heilwell, G., & Spirn, M. (2015). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies. The Lancet,385(9967), 509\u2013516.","journal-title":"The Lancet"},{"issue":"4","key":"10949_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","volume":"36","author":"L da Cruz","year":"2018","unstructured":"da Cruz, L., Fynes, K., Georgiadis, O., Kerby, J., Luo, Y. H., Ahmado, A., Vernon, A., Daniels, J. T., Nommiste, B., & Hasan, S. M. (2018). Phase 1 clinical study of an embryonic stem cell\u2013derived retinal pigment epithelium patch in age-related macular degeneration. Nature Biotechnology, 36(4), 328\u2013337.","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10949_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/STJ-180001","volume":"1","author":"SM Willerth","year":"2019","unstructured":"Willerth, S. M., & Sakiyama-Elbert, S. E. (2019). Combining stem cells and biomaterial scaffolds for constructing tissues and cell delivery. StemJournal, 1(1), 1\u201325.","journal-title":"StemJournal"},{"issue":"1","key":"10949_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/dvdy.24665","volume":"248","author":"JA Fantuzzo","year":"2019","unstructured":"Fantuzzo, J. A., Hart, R. P., Zahn, J. D., & Pang, Z. P. (2019). Compartmentalized devices as tools for investigation of human brain network dynamics. Developmental Dynamics, 248(1), 65\u201377.","journal-title":"Developmental Dynamics"},{"key":"10949_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.reth.2022.12.005","volume":"22","author":"M Mandai","year":"2023","unstructured":"Mandai, M. (2023). Pluripotent stem cell-derived retinal organoid\/cells for retinal regeneration therapies: A review. Regenerative Therapy, 22, 59\u201367.","journal-title":"Regenerative Therapy"},{"issue":"1","key":"10949_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40824-018-0148-4","volume":"22","author":"SG Kwon","year":"2018","unstructured":"Kwon, S. G., Kwon, Y. W., Lee, T. W., Park, G. T., & Kim, J. H. (2018). Recent advances in stem cell therapeutics and tissue engineering strategies. Biomaterials Research, 22(1), 1\u20138.","journal-title":"Biomaterials Research"},{"issue":"10","key":"10949_CR48","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1002\/jcp.26515","volume":"233","author":"J Pizzicannella","year":"2018","unstructured":"Pizzicannella, J., Diomede, F., Merciaro, I., Caputi, S., Tartaro, A., Guarnieri, S., & Trubiani, O. (2018). Endothelial committed oral stem cells as modelling in the relationship between periodontal and cardiovascular disease. Journal of Cellular Physiology, 233(10), 6734\u20136747.","journal-title":"Journal of Cellular Physiology"},{"key":"10949_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.biomaterials.2018.09.036","volume":"198","author":"H Savoji","year":"2019","unstructured":"Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019). Cardiovascular disease models: A game changing paradigm in drug discovery and screening. Biomaterials, 198, 3\u201326.","journal-title":"Biomaterials"},{"issue":"1","key":"10949_CR50","first-page":"43","volume":"10","author":"VK Singh","year":"2015","unstructured":"Singh, V. K., Kumar, N., Kalsan, M., Saini, A., & Chandra, R. (2015). Mechanism of induction: Induced pluripotent stem cells (iPSCs). Journal of Stem Cells,10(1), 43.","journal-title":"Journal of Stem Cells"},{"issue":"1","key":"10949_CR51","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1038\/s41467-021-27488-x","volume":"12","author":"R Sharma","year":"2021","unstructured":"Sharma, R., George, A., Nimmagadda, M., Ortolan, D., Karla, B. S., Qureshy, Z., Bose, D., Dejene, R., Liang, G., & Wan, Q. (2021). Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model. Nature Communications,12(1), 7293.","journal-title":"Nature Communications"},{"issue":"4","key":"10949_CR52","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/jcm4040567","volume":"4","author":"HV Nguyen","year":"2015","unstructured":"Nguyen, H. V., Li, Y., & Tsang, S. H. (2015). Patient-specific iPSC-derived RPE for modeling of retinal diseases. Journal of Clinical Medicine,4(4), 567\u2013578.","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10949_CR53","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","volume":"13","author":"G Schwank","year":"2013","unstructured":"Schwank, G., Koo, B. K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., & van der Ent, C. K. (2013). Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell, 13(6), 653\u2013658.","journal-title":"Cell Stem Cell"},{"issue":"7467","key":"10949_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster, M. A., Renner, M., Martin, C. A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013). Cerebral organoids model human brain development and microcephaly. Nature,501(7467), 373\u2013379.","journal-title":"Nature"},{"issue":"1","key":"10949_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","volume":"7","author":"XY Tang","year":"2022","unstructured":"Tang, X. Y., Wu, S., Wang, D., Chu, C., Hong, Y., Tao, M., Hu, H., Xu, M., Guo, X., & Liu, Y. (2022). Human organoids in basic research and clinical applications. Signal Transduction and Targeted Therapy, 7(1), 168.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10949_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtos.2020.11.004","volume":"19","author":"N Manafi","year":"2021","unstructured":"Manafi, N., Shokri, F., Achberger, K., Hirayama, M., Mohammadi, M. H., Noorizadeh, F., Hong, J., Liebau, S., Tsuji, T., & Quinn, P. M. (2021). Organoids and organ chips in ophthalmology. The Ocular Surface,19, 1\u201315.","journal-title":"The Ocular Surface"},{"issue":"1","key":"10949_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s42003-020-0808-5","volume":"3","author":"A Kallman","year":"2020","unstructured":"Kallman, A., Capowski, E. E., Wang, J., Kaushik, A. M., Jansen, A. D., Edwards, K. L., Chen, L., Berlinicke, C. A., Phillips, J., M., & Pierce, E. A. (2020). Investigating cone photoreceptor development using patient-derived NRL null retinal organoids. Communications Biology, 3(1), 82.","journal-title":"Communications Biology"},{"issue":"6","key":"10949_CR58","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.stem.2018.05.013","volume":"22","author":"JH Stern","year":"2018","unstructured":"Stern, J. H., Tian, Y., Funderburgh, J., Pellegrini, G., Zhang, K., Goldberg, J. L., Ali, R. R., Young, M., Xie, Y., & Temple, S. (2018). Regenerating eye tissues to preserve and restore vision. Cell Stem Cell, 22(6), 834\u2013849.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10949_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/bjo.2004.057687","volume":"89","author":"E Mayer","year":"2005","unstructured":"Mayer, E., Carter, D., Ren, Y., Hughes, E., Rice, C., Halfpenny, C., Scolding, N., & Dick, A. (2005). Neural progenitor cells from postmortem adult human retina. British Journal of Ophthalmology, 89(1), 102\u2013106.","journal-title":"British Journal of Ophthalmology"},{"issue":"12","key":"10949_CR60","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/nn762","volume":"4","author":"M Haruta","year":"2001","unstructured":"Haruta, M., Kosaka, M., Kanegae, Y., Saito, I., Inoue, T., Kageyama, R., Nishida, A., Honda, Y., & Takahashi, M. (2001). Induction of photoreceptor-specific phenotypes in adult mammalian iris tissue. Nature Neuroscience,4(12), 1163\u20131164.","journal-title":"Nature Neuroscience"},{"issue":"8","key":"10949_CR61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/biomedicines9081005","volume":"9","author":"SS Rohiwal","year":"2021","unstructured":"Rohiwal, S. S., Ellederov\u00e1, Z., Ardan, T., & Klima, J. (2021). Advancement in nanostructure-based tissue-engineered biomaterials for retinal degenerative diseases. Biomedicines, 9(8), 1005.","journal-title":"Biomedicines"},{"issue":"8","key":"10949_CR62","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrm3620","volume":"14","author":"FM Watt","year":"2013","unstructured":"Watt, F. M., & Huck, W. T. (2013). Role of the extracellular matrix in regulating stem cell fate. Nature Reviews Molecular Cell Biology,14(8), 467\u2013473.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"5935","key":"10949_CR63","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1171643","volume":"324","author":"DE Discher","year":"2009","unstructured":"Discher, D. E., Mooney, D. J., & Zandstra, P. W. (2009). Growth factors, matrices, and forces combine and control stem cells. Science,324(5935), 1673\u20131677.","journal-title":"Science"},{"issue":"1","key":"10949_CR64","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1073\/pnas.1212677110","volume":"110","author":"AC Barber","year":"2013","unstructured":"Barber, A. C., Hippert, C., Duran, Y., West, E. L., Bainbridge, J. W., Warre-Cornish, K., Luhmann, U. F., Lakowski, J., Sowden, J. C., & Ali, R. R. (2013). Repair of the degenerate retina by photoreceptor transplantation. Proceedings of the National Academy of Sciences of the United States of America,110(1), 354\u2013359.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10949_CR65","doi-asserted-by":"publisher","first-page":"118932","DOI":"10.1016\/j.lfs.2020.118932","volume":"268","author":"P Sharma","year":"2021","unstructured":"Sharma, P., Kumar, A., Dey, A. D., Behl, T., & Chadha, S. (2021). Stem cells and growth factors-based delivery approaches for chronic wound repair and regeneration: A promise to heal from within. Life Sciences, 268, 118932.","journal-title":"Life Sciences"},{"issue":"2","key":"10949_CR66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molmed.2015.12.007","volume":"22","author":"M Zarbin","year":"2016","unstructured":"Zarbin, M. (2016). Cell-based therapy for degenerative retinal disease. Trends in Molecular Medicine, 22(2), 115\u2013134.","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"10949_CR67","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2015.11.036","volume":"164","author":"F Bei","year":"2016","unstructured":"Bei, F., Lee, H. H. C., Liu, X., Gunner, G., Jin, H., Ma, L., Wang, C., Hensch, T. K., Frank, E., & Sanes, J. R. (2016). Restoration of visual function by enhancing conduction in regenerated axons. Cell,164(1), 219\u2013232.","journal-title":"Cell"},{"key":"10949_CR68","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bioactmat.2023.11.008","volume":"33","author":"F Sun","year":"2024","unstructured":"Sun, F., Sun, Y., Wang, X., Zhu, J., Chen, S., Yu, Y., Zhu, M., Xu, W., & Qian, H. (2024). Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1\u03b1\/EZH2\/PGC-1\u03b1 pathway. Bioactive Materials, 33, 444\u2013459.","journal-title":"Bioactive Materials"},{"key":"10949_CR69","doi-asserted-by":"publisher","first-page":"113554","DOI":"10.1016\/j.biopha.2022.113554","volume":"154","author":"N Ebrahim","year":"2022","unstructured":"Ebrahim, N., El-Halim, A., Helal, H. E., El-Azab, O. K., Badr, N. E. E., Hassouna, O. A., Saihati, A. A., Aborayah, H. A., Emam, N. H., & El-Wakeel, H. S. (2022). Effect of bone marrow mesenchymal stem cells-derived exosomes on diabetes-induced retinal injury: Implication of Wnt\/b-catenin signaling pathway. Biomedicine & Pharmacotherapy,154, 113554.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"5","key":"10949_CR70","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.stemcr.2019.09.009","volume":"13","author":"MJ Brooks","year":"2019","unstructured":"Brooks, M. J., Chen, H. Y., Kelley, R. A., Mondal, A. K., Nagashima, K., De Val, N., Li, T., Chaitankar, V., & Swaroop, A. (2019). Improved retinal organoid differentiation by modulating signaling pathways revealed by comparative transcriptome analyses with development in vivo. Stem Cell Reports,13(5), 891\u2013905. https:\/\/doi.org\/10.1016\/j.stemcr.2019.09.009","journal-title":"Stem Cell Reports"},{"issue":"5","key":"10949_CR71","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1007\/s10528-023-10487-6","volume":"62","author":"N Bi","year":"2024","unstructured":"Bi, N., Li, N., Liu, H., & Wang, T. H. (2024). Molecular network mechanism analysis of urine stem cells against retinal aging. Biochemical Genetics, 62(5), 4046\u20134066.","journal-title":"Biochemical Genetics"},{"key":"10949_CR72","doi-asserted-by":"crossref","unstructured":"Gonzalez-Andrades, M., Arg\u00fceso, P., & Gipson, I. (2019). Corneal anatomy. Corneal Regeneration: Therapy and Surgery, 3\u201312.","DOI":"10.1007\/978-3-030-01304-2_1"},{"issue":"2","key":"10949_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jtos.2019.01.002","volume":"17","author":"G Yazdanpanah","year":"2019","unstructured":"Yazdanpanah, G., Haq, Z., Kang, K., Jabbehdari, S., Rosenblatt, M., & Djalilian, A. R. (2019). Strategies for reconstructing the limbal stem cell niche. The Ocular Surface,17(2), 230\u2013240.","journal-title":"The Ocular Surface"},{"issue":"2","key":"10949_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM200007133430202","volume":"343","author":"RJF Tsai","year":"2000","unstructured":"Tsai, R. J. F., Li, L. M., & Chen, J. K. (2000). Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. New England Journal of Medicine,343(2), 86\u201393.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10949_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01855-9","volume":"11","author":"X Wu","year":"2020","unstructured":"Wu, X., Jiang, J., Gu, Z., Zhang, J., Chen, Y., & Liu, X. (2020). Mesenchymal stromal cell therapies: Immunomodulatory properties and clinical progress. Stem Cell Research & Therapy, 11(1), 1\u201316.","journal-title":"Stem Cell Research & Therapy"},{"issue":"5","key":"10949_CR76","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/19768354.2015.1087430","volume":"19","author":"BG Jeon","year":"2015","unstructured":"Jeon, B. G., Jang, S. J., Park, J. S., Subbarao, R. B., Jeong, G. J., Park, B. W., & Rho, G. J. (2015). Differentiation potential of mesenchymal stem cells isolated from human dental tissues into non-mesodermal lineage. Animal Cells and Systems, 19(5), 321\u2013331.","journal-title":"Animal Cells and Systems"},{"issue":"1","key":"10949_CR77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15171\/bi.2016.02","volume":"6","author":"S Azandeh","year":"2016","unstructured":"Azandeh, S., Gharravi, A. M., Orazizadeh, M., Khodadi, A., & Tabar, M. H. (2016). Improvement of mesenchymal stem cell differentiation into the endoderm lineage by four step sequential method in biocompatible biomaterial. BioImpacts,6(1), 9\u201313.","journal-title":"BioImpacts"},{"key":"10949_CR78","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jtos.2021.07.008","volume":"22","author":"L Liang","year":"2021","unstructured":"Liang, L., Luo, X., Zhang, J., Su, W., Zhu, W., Xie, Y., Zhang, N., Peng, Y., Chen, X., & Xiang, A. P. (2021). Safety and feasibility of subconjunctival injection of mesenchymal stem cells for acute severe ocular burns: A single-arm study. The Ocular Surface, 22, 103\u2013109.","journal-title":"The Ocular Surface"},{"key":"10949_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-02129-0","volume":"12","author":"S Galindo","year":"2021","unstructured":"Galindo, S., de la Mata, A., L\u00f3pez-Paniagua, M., Herreras, J. M., P\u00e9rez, I., Calonge, M., & Nieto-Miguel, T. (2021). Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: State of the art. Stem Cell Research & Therapy,12, 1\u201312.","journal-title":"Stem Cell Research & Therapy"},{"issue":"21","key":"10949_CR80","doi-asserted-by":"publisher","first-page":"7834","DOI":"10.3390\/ijms21217834","volume":"21","author":"K Theerakittayakorn","year":"2020","unstructured":"Theerakittayakorn, K., Nguyen, T., Musika, H., Kunkanjanawan, J., Imsoonthornruksa, H., Somredngan, S., Ketudat-Cairns, S., M., & Parnpai, R. (2020). Differentiation induction of human stem cells for corneal epithelial regeneration. International Journal of Molecular Sciences, 21(21), 7834.","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10949_CR81","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jtos.2020.07.009","volume":"18","author":"J He","year":"2020","unstructured":"He, J., Ou, S., Ren, J., Sun, H., He, X., Zhao, Z., Wu, H., Qu, Y., Liu, T., & Jeyalatha, V. (2020). Tissue engineered corneal epithelium derived from clinical-grade human embryonic stem cells. The Ocular Surface, 18(4), 672\u2013680.","journal-title":"The Ocular Surface"},{"issue":"7","key":"10949_CR82","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamapsychiatry.2020.0196","volume":"77","author":"A Kathuria","year":"2020","unstructured":"Kathuria, A., Lopez-Lengowski, K., Jagtap, S. S., McPhie, D., Perlis, R. H., Cohen, B. M., & Karmacharya, R. (2020). Transcriptomic landscape and functional characterization of induced pluripotent stem cell\u2013derived cerebral organoids in schizophrenia. JAMA Psychiatry, 77(7), 745\u2013754.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10949_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03502-8","volume":"16","author":"W Booranapong","year":"2022","unstructured":"Booranapong, W., Kosrirukvongs, P., Duangsa-Ard, S., Kasetsinsombat, K., Sa-Ngiamsuntorn, K., & Wongkajornsilp, A. (2022). Transplantation of autologous cultivated oral mucosal epithelial sheets for limbal stem cell deficiency at Siriraj hospital: A case series. Journal of Medical Case Reports,16(1), Article 298. https:\/\/doi.org\/10.1186\/s13256-022-03502-8","journal-title":"Journal of Medical Case Reports"},{"issue":"8","key":"10949_CR84","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/pat.5340","volume":"32","author":"S Ulag","year":"2021","unstructured":"Ulag, S., Uysal, E., Bedir, T., Sengor, M., Ekren, N., Ustundag, C. B., Midha, S., Kalaskar, D. M., & Gunduz, O. (2021). Recent developments and characterization techniques in 3D printing of corneal stroma tissue. Polymers for Advanced Technologies, 32(8), 3287\u20133296.","journal-title":"Polymers for Advanced Technologies"},{"key":"10949_CR85","doi-asserted-by":"publisher","first-page":"101011","DOI":"10.1016\/j.preteyeres.2021.101011","volume":"87","author":"A Kumar","year":"2022","unstructured":"Kumar, A., Yun, H., Funderburgh, M. L., & Du, Y. (2022). Regenerative therapy for the cornea. Progress in Retinal and Eye Research, 87, 101011.","journal-title":"Progress in Retinal and Eye Research"},{"issue":"4","key":"10949_CR86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.61.4.22","volume":"61","author":"M El Zarif","year":"2020","unstructured":"El Zarif, M., Jawad, K. A., Barrio, D., Jawad, J. L. A., Palaz\u00f3n-Bru, Z. A., de Miguel, A., Saba, M. P., Makdissy, P., N., & Ali\u00f3, J. L. (2020). Corneal stroma cell density evolution in keratoconus Corneas following the implantation of adipose mesenchymal stem cells And corneal laminas: An in vivo confocal microscopy study. Investigative Ophthalmology and Visual Science, 61(4), 22\u201322.","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10949_CR87","doi-asserted-by":"publisher","first-page":"108495","DOI":"10.1016\/j.exer.2021.108495","volume":"205","author":"LJ Jeang","year":"2021","unstructured":"Jeang, L. J., Margo, C. E., & Espana, E. M. (2021). Diseases of the corneal endothelium. Experimental Eye Research, 205, 108495.","journal-title":"Experimental Eye Research"},{"key":"10949_CR88","doi-asserted-by":"publisher","first-page":"100904","DOI":"10.1016\/j.preteyeres.2020.100904","volume":"82","author":"MO Price","year":"2021","unstructured":"Price, M. O., Mehta, J. S., Jurkunas, U. V., & Price, F. W., Jr. (2021). Corneal endothelial dysfunction: Evolving understanding and treatment options. Progress in Retinal and Eye Research,82, 100904.","journal-title":"Progress in Retinal and Eye Research"},{"issue":"4","key":"10949_CR89","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ophtha.2020.09.002","volume":"128","author":"K Numa","year":"2021","unstructured":"Numa, K., Imai, K., Ueno, M., Kitazawa, K., Tanaka, H., Bush, J. D., Teramukai, S., Okumura, N., Koizumi, N., & Hamuro, J. (2021). Five-year follow-up of first 11 patients undergoing injection of cultured corneal endothelial cells for corneal endothelial failure. Ophthalmology, 128(4), 504\u2013514.","journal-title":"Ophthalmology"},{"issue":"1","key":"10949_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1455-y","volume":"10","author":"S Moradi","year":"2019","unstructured":"Moradi, S., Mahdizadeh, H., \u0160ari\u0107, T., Kim, J., Harati, J., Shahsavarani, H., Greber, B., & Moore, J. B. (2019). Research and therapy with induced pluripotent stem cells (iPSCs): Social, legal, and ethical considerations. Stem Cell Research & Therapy,10(1), 1\u201313.","journal-title":"Stem Cell Research & Therapy"},{"issue":"2","key":"10949_CR91","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","volume":"31","author":"M Almasieh","year":"2012","unstructured":"Almasieh, M., Wilson, A. M., Morquette, B., Vargas, J. L. C., & Di Polo, A. (2012). The molecular basis of retinal ganglion cell death in glaucoma. Progress in Retinal and Eye Research, 31(2), 152\u2013181.","journal-title":"Progress in Retinal and Eye Research"},{"key":"10949_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7869130","author":"CR Harrell","year":"2019","unstructured":"Harrell, C. R., Fellabaum, C., Arsenijevic, A., Markovic, B. S., Djonov, V., & Volarevic, V. (2019). Therapeutic potential of mesenchymal stem cells and their secretome in the treatment of glaucoma. Stem Cells International. https:\/\/doi.org\/10.1155\/2019\/7869130","journal-title":"Stem Cells International"},{"issue":"2","key":"10949_CR93","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1167\/iovs.17-22855","volume":"59","author":"B Mead","year":"2018","unstructured":"Mead, B., Amaral, J., & Tomarev, S. (2018). Mesenchymal stem cell-derived small extracellular vesicles promote neuroprotection in rodent models of glaucoma. Investigative Ophthalmology & Visual Science,59(2), 702\u2013714. https:\/\/doi.org\/10.1167\/iovs.17-22855","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10949_CR94","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/stem.2722","volume":"36","author":"A Osborne","year":"2018","unstructured":"Osborne, A., Sanderson, J., & Martin, K. R. (2018). Neuroprotective effects of human mesenchymal stem cells and platelet-derived growth factor on human retinal ganglion cells. Stem Cells, 36(1), 65\u201378.","journal-title":"Stem Cells"},{"issue":"10","key":"10949_CR95","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.2217\/rme-2020-0044","volume":"15","author":"Y Sung","year":"2020","unstructured":"Sung, Y., Lee, S. M., Park, M., Choi, H. J., Kang, S., Choi, B. I., & Lew, H. (2020). Treatment of traumatic optic neuropathy using human placenta-derived mesenchymal stem cells in Asian patients. Regenerative Medicine, 15(10), 2163\u20132179.","journal-title":"Regenerative Medicine"},{"key":"10949_CR96","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10633-021-09817-z","volume":"143","author":"CAP Vilela","year":"2021","unstructured":"Vilela, C. A. P., Messias, A., Calado, R. T., Siqueira, R. C., Silva, M. J. L., Covas, D. T., & Paula, J. S. (2021). Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma. Documenta Ophthalmologica, 143, 33\u201338.","journal-title":"Documenta Ophthalmologica"},{"key":"10949_CR97","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S365486","author":"N Cross","year":"2022","unstructured":"Cross, N., van Steen, C., Zegaoui, Y., Satherley, A., & Angelillo, L. (2022). Retinitis pigmentosa: Burden of disease and current unmet needs. Clinical Ophthalmology. https:\/\/doi.org\/10.2147\/OPTH.S365486","journal-title":"Clinical Ophthalmology"},{"issue":"6","key":"10949_CR98","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1167\/iovs.61.6.56","volume":"61","author":"M Xu","year":"2020","unstructured":"Xu, M., Zhai, Y., & MacDonald, I. M. (2020). Visual field progression in retinitis pigmentosa. Investigative Ophthalmology & Visual Science,61(6), 56\u201356.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10949_CR99","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cell.2015.03.023","volume":"161","author":"N A\u00eft-Ali","year":"2015","unstructured":"A\u00eft-Ali, N., Fridlich, R., Millet-Puel, G., Cl\u00e9rin, E., Delalande, F., Jaillard, C., Blond, F., Perrocheau, L., Reichman, S., Byrne, L. C., Olivier-Bandini, A., Bellalou, J., Moyse, E., Bouillaud, F., Nicol, X., Dalkara, D., van Dorsselaer, A., Sahel, J. A., & L\u00e9veillard, T. (2015). Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis. Cell,161(4), 817\u2013832. https:\/\/doi.org\/10.1016\/j.cell.2015.03.023","journal-title":"Cell"},{"key":"10949_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0661-8","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu, Y., Chen, S. J., Li, S. Y., Qu, L. H., Meng, X. H., Wang, Y., Xu, H. W., Liang, Z. Q., & Yin, Z. Q. (2017). Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients. Stem Cell Research & Therapy, 8, 1\u201312.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"10949_CR101","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13287-020-01870-w","volume":"11","author":"E \u00d6zmert","year":"2020","unstructured":"\u00d6zmert, E., & Arslan, U. (2020). Management of retinitis pigmentosa by wharton\u2019s jelly-derived mesenchymal stem cells: Prospective analysis of 1-year results. Stem Cell Research & Therapy,11(1), 353. https:\/\/doi.org\/10.1186\/s13287-020-01870-w","journal-title":"Stem Cell Research & Therapy"},{"issue":"9","key":"10949_CR102","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.18240\/ijo.2020.09.14","volume":"13","author":"NS Kahraman","year":"2020","unstructured":"Kahraman, N. S., & Oner, A. (2020). Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: A 6-month follow-up results of a phase 3 trial. International Journal of Ophthalmology,13(9), 1423.","journal-title":"International Journal of Ophthalmology"},{"issue":"4","key":"10949_CR103","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s12015-020-10090-x","volume":"17","author":"S Adak","year":"2021","unstructured":"Adak, S., Magdalene, D., Deshmukh, S., Das, D., & Jaganathan, B. G. (2021). A review on mesenchymal stem cells for treatment of retinal diseases. Stem Cell Reviews and Reports,17(4), 1154\u20131173. https:\/\/doi.org\/10.1007\/s12015-020-10090-x","journal-title":"Stem Cell Reviews and Reports"},{"issue":"12","key":"10949_CR104","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.stem.2023.11.004","volume":"30","author":"Y Hirami","year":"2023","unstructured":"Hirami, Y., Mandai, M., Sugita, S., Maeda, A., Maeda, T., Yamamoto, M., Uyama, H., Yokota, S., Fujihara, M., & Igeta, M. (2023). Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa. Cell Stem Cell, 30(12), 1585\u20131596. e1586.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10949_CR105","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11427-023-2531-3","volume":"67","author":"CJ Zhang","year":"2024","unstructured":"Zhang, C. J., & Jin, Z. B. (2024). Turning point of organoid transplantation: First-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa. Science China Life Sciences,67(5), 1082\u20131084.","journal-title":"Science China Life Sciences"},{"issue":"1","key":"10949_CR106","doi-asserted-by":"publisher","first-page":"100589","DOI":"10.1016\/j.xops.2024.100589","volume":"5","author":"SS Park","year":"2025","unstructured":"Park, S. S., Bauer, G., Fury, B., Abedi, M., Perotti, N., Colead-Bergum, D., & Nolta, J. A. (2025). Phase I study of intravitreal injection of autologous CD34\u2009+\u2009stem cells from bone marrow in eyes with vision loss from retinitis pigmentosa. Ophthalmology Science, 5(1), 100589.","journal-title":"Ophthalmology Science"},{"issue":"11","key":"10949_CR107","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai, M., Watanabe, A., Kurimoto, Y., Hirami, Y., Morinaga, C., Daimon, T., Fujihara, M., Akimaru, H., Sakai, N., & Shibata, Y. (2017). Autologous induced stem-cell\u2013derived retinal cells for macular degeneration. New England Journal of Medicine, 376(11), 1038\u20131046.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10949_CR108","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1076\/opge.24.2.75.13996","volume":"24","author":"RK Koenekoop","year":"2003","unstructured":"Koenekoop, R. K. (2003). The gene for Stargardt disease, ABCA4, is a major retinal gene: A mini-review. Ophthalmic Genetics,24(2), 75\u201380.","journal-title":"Ophthalmic Genetics"},{"issue":"11","key":"10949_CR109","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.ophtha.2018.04.037","volume":"125","author":"MS Mehat","year":"2018","unstructured":"Mehat, M. S., Sundaram, V., Ripamonti, C., Robson, A. G., Smith, A. J., Borooah, S., Robinson, M., Rosenthal, A. N., Innes, W., Weleber, R. G., Lee, R. W. J., Crossland, M., Rubin, G. S., Dhillon, B., Steel, D. H. W., Anglade, E., Lanza, R. P., Ali, R. R., Michaelides, M., & Bainbridge, J. W. B. (2018). Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration. Ophthalmology,125(11), 1765\u20131775. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.037","journal-title":"Ophthalmology"},{"issue":"4","key":"10949_CR110","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00277-021-04433-y","volume":"100","author":"F Pegoraro","year":"2021","unstructured":"Pegoraro, F., & Favre, C. (2021). Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation. Annals of Hematology,100(4), 865\u2013878.","journal-title":"Annals of Hematology"},{"key":"10949_CR111","doi-asserted-by":"publisher","first-page":"100950","DOI":"10.1016\/j.preteyeres.2021.100950","volume":"84","author":"S Sugita","year":"2021","unstructured":"Sugita, S., Mandai, M., Kamao, H., & Takahashi, M. (2021). Immunological aspects of RPE cell transplantation. Progress in Retinal and Eye Research, 84, 100950.","journal-title":"Progress in Retinal and Eye Research"},{"issue":"10","key":"10949_CR112","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1167\/iovs.18-24769","volume":"59","author":"S Sugita","year":"2018","unstructured":"Sugita, S., Makabe, K., Fujii, S., & Takahashi, M. (2018). Detection of complement activators in immune attack eyes after iPS-derived retinal pigment epithelial cell transplantation. Investigative Ophthalmology & Visual Science,59(10), 4198\u20134209.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10949_CR113","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3389\/fimmu.2019.01007","volume":"10","author":"DH Park","year":"2019","unstructured":"Park, D. H., Connor, K. M., & Lambris, J. D. (2019). The challenges and promise of complement therapeutics for ocular diseases. Frontiers in Immunology, 10, 1007.","journal-title":"Frontiers in Immunology"},{"key":"10949_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103757","author":"S Rathi","year":"2023","unstructured":"Rathi, S., Hasan, R., Ueffing, M., & Clark, S. J. (2023). Therapeutic targeting of the complement system in ocular disease. Drug Discovery Today. https:\/\/doi.org\/10.1016\/j.drudis.2023.103757","journal-title":"Drug Discovery Today"},{"key":"10949_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-024-00219-9","author":"A Hotta","year":"2024","unstructured":"Hotta, A., Schrepfer, S., & Nagy, A. (2024). Genetically engineered hypoimmunogenic cell therapy. Nature Reviews Bioengineering. https:\/\/doi.org\/10.1038\/s44222-024-00219-9","journal-title":"Nature Reviews Bioengineering"},{"issue":"4","key":"10949_CR116","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., & Nomura, M. (2019). Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell, 24(4), 566\u2013578. e567.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10949_CR117","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1242\/dev.060426","volume":"139","author":"KK Niakan","year":"2012","unstructured":"Niakan, K. K., Han, J., Pedersen, R. A., Simon, C., & Pera, R. A. R. (2012). Human pre-implantation embryo development. Development (Cambridge, England),139(5), 829\u2013841.","journal-title":"Development (Cambridge, England)"},{"issue":"3","key":"10949_CR118","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.stem.2009.02.009","volume":"4","author":"GQ Daley","year":"2009","unstructured":"Daley, G. Q., Lensch, M. W., Jaenisch, R., Meissner, A., Plath, K., & Yamanaka, S. (2009). Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell, 4(3), 200\u2013201.","journal-title":"Cell Stem Cell"},{"key":"10949_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt474","volume":"5","author":"NM King","year":"2014","unstructured":"King, N. M., & Perrin, J. (2014). Ethical issues in stem cell research and therapy. Stem Cell Research & Therapy,5, 1\u20136.","journal-title":"Stem Cell Research & Therapy"},{"issue":"6","key":"10949_CR120","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.stemcr.2021.05.012","volume":"16","author":"R Lovell-Badge","year":"2021","unstructured":"Lovell-Badge, R., Anthony, E., Barker, R. A., Bubela, T., Brivanlou, A. H., Carpenter, M., Charo, R. A., Clark, A., Clayton, E., & Cong, Y. (2021). ISSCR guidelines for stem cell research and clinical translation: The 2021 update. Stem Cell Reports, 16(6), 1398\u20131408.","journal-title":"Stem Cell Reports"},{"key":"10949_CR121","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12015-017-9760-2","volume":"13","author":"GS Oggu","year":"2017","unstructured":"Oggu, G. S., Sasikumar, S., Reddy, N., Ella, K. K. R., Rao, C. M., & Bokara, K. K. (2017). Gene delivery approaches for mesenchymal stem cell therapy: Strategies to increase efficiency and specificity. Stem Cell Reviews and Reports, 13, 725\u2013740.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"2","key":"10949_CR122","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s13346-022-01231-5","volume":"13","author":"L Wang","year":"2023","unstructured":"Wang, L., & Zhang, H. (2023). Ocular barriers as a double-edged sword: Preventing and facilitating drug delivery to the retina. Drug Delivery and Translational Research, 13(2), 547\u2013567.","journal-title":"Drug Delivery and Translational Research"},{"issue":"5","key":"10949_CR123","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/jcm10050981","volume":"10","author":"JT Cox","year":"2021","unstructured":"Cox, J. T., Eliott, D., & Sobrin, L. (2021). Inflammatory complications of intravitreal anti-VEGF injections. Journal of Clinical Medicine, 10(5), 981.","journal-title":"Journal of Clinical Medicine"},{"key":"10949_CR124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bioactmat.2022.01.011","volume":"17","author":"X Han","year":"2022","unstructured":"Han, X., Alu, A., Liu, H., Shi, Y., Wei, X., Cai, L., & Wei, Y. (2022). Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy. Bioactive Materials, 17, 29\u201348.","journal-title":"Bioactive Materials"},{"key":"10949_CR125","doi-asserted-by":"publisher","first-page":"1259435","DOI":"10.3389\/fchem.2023.1259435","volume":"11","author":"AK Dubey","year":"2023","unstructured":"Dubey, A. K., & Mostafavi, E. (2023). Biomaterials-mediated CRISPR\/Cas9 delivery: Recent challenges and opportunities in gene therapy. Frontiers in Chemistry, 11, 1259435.","journal-title":"Frontiers in Chemistry"},{"issue":"4","key":"10949_CR126","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.stemcr.2018.02.003","volume":"10","author":"WL Deng","year":"2018","unstructured":"Deng, W. L., Gao, M. L., Lei, X. L., Lv, J. N., Zhao, H., He, K. W., Xia, X. X., Li, L. Y., Chen, Y. C., & Li, Y. P. (2018). Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients. Stem Cell Reports, 10(4), 1267\u20131281.","journal-title":"Stem Cell Reports"},{"issue":"6","key":"10949_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/genes12060805","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu, X., Lillywhite, J., Zhu, W., Huang, Z., Clark, A. M., Gosstola, N., Maguire, C. T., Dykxhoorn, D., Chen, Z. Y., & Yang, J. (2021). Generation and genetic correction of USH2A c. 2299delG mutation in patient-derived induced pluripotent stem cells. Genes,12(6), Article 805.","journal-title":"Genes"},{"issue":"8","key":"10949_CR128","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.drudis.2019.04.009","volume":"24","author":"MA Zadeh","year":"2019","unstructured":"Zadeh, M. A., Khoder, M., Al-Kinani, A. A., Younes, H. M., & Alany, R. G. (2019). Retinal cell regeneration using tissue engineered polymeric scaffolds. Drug Discovery Today, 24(8), 1669\u20131678.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10949_CR129","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jbm.a.35897","volume":"105","author":"S Nadri","year":"2017","unstructured":"Nadri, S., Nasehi, F., & Barati, G. (2017). Effect of parameters on the quality of core-shell fibrous scaffold for retinal differentiation of conjunctiva mesenchymal stem cells. Journal of Biomedical Materials Research Part A, 105(1), 189\u2013197.","journal-title":"Journal of Biomedical Materials Research Part A"},{"key":"10949_CR130","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.actbio.2017.11.058","volume":"67","author":"JK Gandhi","year":"2018","unstructured":"Gandhi, J. K., Manzar, Z., Bachman, L. A., Andrews-Pfannkoch, C., Knudsen, T., Hill, M., Schmidt, H., Iezzi, R., Pulido, J. S., & Marmorstein, A. D. (2018). Fibrin hydrogels as a xenofree and rapidly degradable support for transplantation of retinal pigment epithelium monolayers. Acta Biomaterialia, 67, 134\u2013146.","journal-title":"Acta Biomaterialia"},{"issue":"4","key":"10949_CR131","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1021\/acsnano.1c10635","volume":"16","author":"C Salvador-Morales","year":"2022","unstructured":"Salvador-Morales, C., & Grodzinski, P. (2022). Nanotechnology tools enabling biological discovery. ACS Nano, 16(4), 5062\u20135084.","journal-title":"ACS Nano"},{"key":"10949_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-017-0310-5","volume":"15","author":"M Wei","year":"2017","unstructured":"Wei, M., Li, S., & Le, W. (2017). Nanomaterials modulate stem cell differentiation: Biological interaction and underlying mechanisms. Journal of Nanobiotechnology, 15, 1\u201313.","journal-title":"Journal of Nanobiotechnology"},{"key":"10949_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102314","volume":"31","author":"Y Polo","year":"2021","unstructured":"Polo, Y., Luzuriaga, J., Iturri, J., Irastorza, I., Toca-Herrera, J. L., Ibarretxe, G., Unda, F., Sarasua, J. R., Pineda, J. R., & Larra\u00f1aga, A. (2021). Nanostructured scaffolds based on bioresorbable polymers and graphene oxide induce the aligned migration and accelerate the neuronal differentiation of neural stem cells. Nanomedicine: Nanotechnology, Biology, and Medicine,31, Article 102314.","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"12","key":"10949_CR134","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/jfb14120556","volume":"14","author":"A Moeinzadeh","year":"2023","unstructured":"Moeinzadeh, A., Ashtari, B., Garcia, H., Koruji, M., Velazquez, C. A., Bagher, Z., Barati, M., Shabani, R., & Davachi, S. M. (2023). The effect of chitosan\/alginate\/graphene oxide nanocomposites on proliferation of mouse spermatogonial stem cells. Journal of Functional Biomaterials, 14(12), 556.","journal-title":"Journal of Functional Biomaterials"},{"key":"10949_CR135","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S290331","author":"A Sharma","year":"2021","unstructured":"Sharma, A., & Jaganathan, B. G. (2021). Stem cell therapy for retinal degeneration: The evidence to date. Biologics: Targets and Therapy. https:\/\/doi.org\/10.2147\/BTT.S290331","journal-title":"Biologics: Targets and Therapy"},{"issue":"2","key":"10949_CR136","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/term.1947","volume":"11","author":"S Jasty","year":"2017","unstructured":"Jasty, S., Suriyanarayanan, S., & Krishnakumar, S. (2017). Influence of self-assembling peptide nanofibre scaffolds on retinal differentiation potential of stem\/progenitor cells derived from ciliary pigment epithelial cells. Journal of Tissue Engineering and Regenerative Medicine, 11(2), 509\u2013518.","journal-title":"Journal of Tissue Engineering and Regenerative Medicine"},{"issue":"15","key":"10949_CR137","first-page":"3142","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu, J., Wang, D., Liu, D., Fan, Z., Zhang, H., Liu, O., Ding, G., Gao, R., Zhang, C., & Ding, Y. (2012). Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood the Journal of the American Society of Hematology, 120(15), 3142\u20133151.","journal-title":"Blood the Journal of the American Society of Hematology"},{"key":"10949_CR138","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajo.2017.04.006","volume":"179","author":"AC Ho","year":"2017","unstructured":"Ho, A. C., Chang, T. S., Samuel, M., Williamson, P., Willenbucher, R. F., & Malone, T. (2017). Experience with a subretinal cell-based therapy in patients with geographic atrophy secondary to age-related macular degeneration. American Journal of Ophthalmology, 179, 67\u201380.","journal-title":"American Journal of Ophthalmology"},{"key":"10949_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-02122-7","volume":"12","author":"A Tuekprakhon","year":"2021","unstructured":"Tuekprakhon, A., Sangkitporn, S., Trinavarat, A., Pawestri, A. R., Vamvanij, V., Ruangchainikom, M., Luksanapruksa, P., Pongpaksupasin, P., Khorchai, A., & Dambua, A. (2021). Intravitreal autologous mesenchymal stem cell transplantation: A non-randomized phase I clinical trial in patients with retinitis pigmentosa. Stem Cell Research & Therapy, 12, 1\u201315.","journal-title":"Stem Cell Research & Therapy"},{"issue":"10","key":"10949_CR140","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4103\/1673-5374.193251","volume":"11","author":"JN Weiss","year":"2016","unstructured":"Weiss, J. N., Levy, S., & Benes, S. C. (2016). Stem cell ophthalmology treatment study (SCOTS): Bone marrow-derived stem cells in the treatment of Leber\u2019s hereditary optic neuropathy. Neural Regeneration Research,11(10), 1685\u20131694.","journal-title":"Neural Regeneration Research"},{"issue":"6","key":"10949_CR141","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/ICO.0000000000002646","volume":"40","author":"M El Zarif","year":"2021","unstructured":"El Zarif, M., Ali\u00f3, J. L., Barrio, D., Jawad, J. L. A., Palaz\u00f3n-Bru, K. A., Jawad, A., De Miguel, Z. A., & Makdissy, N. (2021). Corneal stromal regeneration therapy for advanced keratoconus: Long-term outcomes at 3 years. Cornea,40(6), 741\u2013754.","journal-title":"Cornea"},{"issue":"2","key":"10949_CR142","first-page":"10","volume":"8","author":"JN Weiss","year":"2021","unstructured":"Weiss, J. N., & Levy, S. (2021). Stem cell ophthalmology treatment study (SCOTS): Bone marrow-derived stem cells in the treatment of Stargardt disease. Medicines (Basel),8(2), 10.","journal-title":"Medicines (Basel)"},{"key":"10949_CR143","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2019.11.01","author":"JN Weiss","year":"2019","unstructured":"Weiss, J. N., & Levy, S. (2019). Stem cell ophthalmology treatment study (SCOTS): Bone marrow derived stem cells in the treatment of dominant optic atrophy. Stem Cell Investigation. https:\/\/doi.org\/10.21037\/sci.2019.11.01","journal-title":"Stem Cell Investigation"},{"key":"10949_CR144","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2019.08.07","author":"JN Weiss","year":"2019","unstructured":"Weiss, J. N., & Levy, S. (2019). Stem cell ophthalmology treatment study (SCOTS): Bone marrow derived stem cells in the treatment of Usher syndrome. Stem Cell Investigation. https:\/\/doi.org\/10.21037\/sci.2019.08.07","journal-title":"Stem Cell Investigation"},{"key":"10949_CR145","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2018.04.02","author":"JN Weiss","year":"2018","unstructured":"Weiss, J. N., & Levy, S. (2018). Stem cell ophthalmology treatment study: Bone marrow derived stem cells in the treatment of retinitis pigmentosa. Stem Cell Investigation. https:\/\/doi.org\/10.21037\/sci.2018.04.02","journal-title":"Stem Cell Investigation"},{"issue":"4","key":"10949_CR146","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/medicines7040016","volume":"7","author":"JN Weiss","year":"2020","unstructured":"Weiss, J. N., & Levy, S. (2020). Stem cell ophthalmology treatment study (SCOTS): Bone marrow-derived stem cells in the treatment of age-related macular degeneration. Medicines, 7(4), 16.","journal-title":"Medicines"},{"key":"10949_CR147","doi-asserted-by":"crossref","unstructured":"Weiss, J. N., Levy, S., & Benes, S. C. (2017). Stem cell ophthalmology treatment study: Bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION). Stem Cell Investigation, 4.","DOI":"10.21037\/sci.2017.11.05"},{"issue":"4","key":"10949_CR148","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/jop.2022.0156","volume":"39","author":"AC Larsen","year":"2023","unstructured":"Larsen, A. C., M\u00f8ller-Hansen, M., Wiencke, A. K., Terslev, L., Torp-Pedersen, S., & Heegaard, S. (2023). Ultrasound-guided transcutaneous injection in the lacrimal gland: A description of sonoanatomy and technique. Journal of Ocular Pharmacology and Therapeutics, 39(4), 275\u2013278.","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10949_CR149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1471-y","volume":"11","author":"E \u00d6zmert","year":"2020","unstructured":"\u00d6zmert, E., & Arslan, U. (2020). Management of retinitis pigmentosa by wharton\u2019s jelly-derived mesenchymal stem cells: Prospective analysis of 1-year results. Stem Cell Research & Therapy, 11, 1\u201317.","journal-title":"Stem Cell Research & Therapy"},{"issue":"9817","key":"10949_CR150","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","volume":"379","author":"SD Schwartz","year":"2012","unstructured":"Schwartz, S. D., Hubschman, J. P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012). Embryonic stem cell trials for macular degeneration: A preliminary report. The Lancet,379(9817), 713\u2013720.","journal-title":"The Lancet"},{"issue":"11","key":"10949_CR151","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.ophtha.2018.04.037","volume":"125","author":"MS Mehat","year":"2018","unstructured":"Mehat, M. S., Sundaram, V., Ripamonti, C., Robson, A. G., Smith, A. J., Borooah, S., Robinson, M., Rosenthal, A. N., Innes, W., & Weleber, R. G. (2018). Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration. Ophthalmology, 125(11), 1765\u20131775.","journal-title":"Ophthalmology"},{"issue":"6","key":"10949_CR152","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/bjophthalmol-2020-316225","volume":"105","author":"Y Sung","year":"2021","unstructured":"Sung, Y., Lee, M. J., Choi, J., Jung, S. Y., Chong, S. Y., Sung, J. H., Shim, S. H., & Song, W. K. (2021). Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients. British Journal of Ophthalmology, 105(6), 829\u2013837.","journal-title":"British Journal of Ophthalmology"},{"issue":"435","key":"10949_CR153","doi-asserted-by":"publisher","first-page":"eaao4097","DOI":"10.1126\/scitranslmed.aao4097","volume":"10","author":"AH Kashani","year":"2018","unstructured":"Kashani, A. H., Lebkowski, J. S., Rahhal, F. M., Avery, R. L., Salehi-Had, H., Dang, W., Lin, C. M., Mitra, D., Zhu, D., & Thomas, B. B. (2018). A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Science Translational Medicine, 10(435), eaao4097.","journal-title":"Science Translational Medicine"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-10949-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:02:55Z","timestamp":1759896175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-10949-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":153,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10949"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-10949-x","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"16 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors provide their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}